Abstract
Cytomegalovirus (CMV) remains an important infectious complication that has a significant impact on morbidity and mortality in lung transplant recipients (LTRs). We have shown that CMV primary infection, defined by de novo viremia, frequently occurs in mismatched, high-risk donor+/recipient- (D+R-) LTRs who either establish viral control (controllers) or demonstrate relapsing viremia (relapsers). Among a cohort of D+R- LTRs, we previously demonstrated that increased T-bet induction in the CD8+ T cell pool correlated with effector function and durable viral control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
